Home › Therapeutic areas › Respiratory › Cystic Fibrosis

Cystic Fibrosis (3 companies)

Companies with an active program in Cystic Fibrosis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
FDMT 4D Molecular Therapeutics OphthalmologyRespiratory Rare 1 Phase 3 $608M 5
SION Sionna Therapeutics Respiratory Rare 5 Phase 2 $139M 5
VTVT vTv Therapeutics HematologyMetabolic+1 Rare 1 Phase 3 $69.4M 9